Thrombin, a glycosylated trypsin-like serine protease, is formed from prothrombin, which is mainly synthesized by the liver and secreted into the bloodstream. Previous data showed that thrombin might be produced locally in the brain (Dihanich et al., 1991) . Thrombin level are upregulated in the CNS after brain injury, such as a primary intracerebral hemorrhage and brain trauma (Xi et al., 2003) . After global cerebral ischemia prothrombin mRNA has been found to increase (Riek-Burchardt et al., 2002) . Till now the normal physiological role for thrombin in the CNS is unknown, but some studies have shown that thrombin, at low concentration acting on thrombin receptors (protease-activated receptors, PARs), induces neuroprotection in ischemic and hemorrhagic injury and at high concentration causes brain damage (Striggow et al., 2000; Xi et al., 2003) . Some recent data showed that thrombin by activating PAR-1 induced neurodegeneration of dopaminergic neurons in the substantia nigra (Carreno-Muller et al., 2003) and of neurons affected by focal ischemic situation (Junge et al., 2003) . Moreover, a considerable number of studies have demonstrated that thrombin is an important pathophysiological modulator of the inflammatory response in the brain (refs. in Boven et al., 2003; Wang and Reiser, 2003) . Meanwhile, accumulating evidence has also indicated that thrombin and its receptors trigger protective or apoptotic effects on neurons and glial cells. All these results underline the importance of thrombin in regulating pathophysiological processes in the CNS.
PARs belong to the superfamily of G protein-coupled receptors. To date, four members of the PAR family have been identified. PAR-1, PAR-3 and PAR-4 are thrombin receptors; trypsin, as agonist of PAR-2, can activate PAR-1 and PAR-4 (Ishihara et al., 1997; Wang et al., 2002a; Xu et al., 1998) . Activation of PARs is initiated through proteolytic cleavage of the extracellular N-terminus of the receptor. This results in the generation of a new N-terminal peptide which as a tethered ligand interacts with extracellular loop-2 of the receptor to induce intracellular signal transduction (Macfarlane et al., 2001; Wang and Reiser, 2003) . PARs are expressed in many tissues by a wide variety of cells, such as endothelial cells, platelets, fibroblasts, smooth muscle cells, *Corresponding author. Tel: ϩ49-391-671-3088; fax: ϩ49-391-671-3097. E-mail address: georg.reiser@medizin.uni-magdeburg. de (G. Reiser) . Abbreviations: AP, activating peptide; bp, base pair; CNP, 2Ј,3Ј-cyclic nucleotide 3Ј-phosphodiesterase; DMEM, Dulbecco's Modified Eagle medium; GAPDH, glyceraldehyde phosphate dehydrogenase; GYPGKF, H-Gly-Tyr-Pro-Gly-Lys-Phe-OH, (mouse protease-activated receptor-4 activating peptide); HBS, HEPES-buffered saline; IL, interleukin; InsP 3 , inositol 1,4,5-trisphosphate; PARs, proteaseactivated receptors; PLC, phospholipase C; PTX, pertussis toxin; RT-PCR, reverse transcription-polymerase chain reaction; SLIGRL, H-Ser-Leu-Ile-Gly-Arg-Leu-OH (rat PAR-2 activating peptide); TFRGAP, H-Thr-Phe-Arg-Gly-Ala-Pro-OH (human PAR-3 activating peptide); TRag, Ala-pFluoro-Phe-Arg-Cha-HomoArg-Tyr-NH 2 (synthetic thrombin receptor agonist peptide); U73122, phospholipase C antagonist; U73343, inactive analog of U73122; YFLLRNP, ␣-thrombin (protease-activated receptor-1) antagonist peptide; 2-APB, 2-aminoethoxydiphenylborate (non-competitive InsP 3 receptor antagonist). monocytes, osteoblasts, neurons, glia, and mast cells (Dihanich et al., 1991; Nishikawa et al., 2000; Strukova, 2001) , where they are involved in several physiological and pathological processes, including growth and development, mitogenesis and inflammation. Our previous studies have shown that rat astrocytes in primary cultures functionally express all four types of PARs (Ubl et al., 1998; Wang et al., 2002a) . Thus, the roles of PARs in astrocytes are well established (Wang and Reiser, 2003) .
Oligodendrocytes, as major glial cells in brain, are mainly responsible for the formation of myelin in the CNS. As recently suggested, oligodendrocytes can also provide trophic support for neuronal survival and function and may complement astrocytes in this ability (Du and Dreyfus, 2002) . In addition, oligodendrocytes are vulnerable to various insults and their damage strongly affects brain functions (Levine et al., 2001) . Thus, oligodendrocytes might play an important role in inflammatory diseases such as multiple sclerosis (Lassmann, 1998) and other demyelinating/hypomyelinating disorders (Vela et al., 1998) .
Several studies indicate that PARs are instrumental in inflammation (Cirino et al., 1996; Fiorucci and Distrutti, 2002; Seeliger et al., 2003; Vergnolle et al., 1999a; Vergnolle et al., 1999b) . The activation of PARs can induce inflammatory mediators, such as interleukin (IL)-6, IL-8 and prostaglandin E 2 , and their release from human respiratory epithelial cells (Asokananthan et al., 2002) . The activation of PARs can also result in a rise in the intracellular Ca 2ϩ concentration in different types of cells, such as rat astrocytes, C6 glioma cells, human respiratory epithelial cells, human platelets and endothelial cells, human bronchial epithelial cells, and human airway smooth muscle cells (Asokananthan et al., 2002; Berger et al., 2001; Molino et al., 1995; Ubl et al., 1998 Ubl et al., , 2002 . The [Ca 2ϩ ] i response is characterized by two distinct phases, firstly a fast, transient rise corresponding to the release of Ca 2ϩ from intracellular stores and secondly, a sustained increase due to entry of Ca 2ϩ across the plasmalemma. Each phase, Ca 2ϩ release and entry, can regulate discrete cellular functions (Moore et al., 1998) .
Calcium, an important second messenger, has been shown to play a role in the regulation of proliferation, invasion and metastatic potential in tumor cells (Cole and Kohn, 1994) . Moreover, calcium-mediated signaling is one of the mechanisms by which CNS cells communicate with each other and modulate the activity of adjacent cells (Pasti et al., 1997) . Presence and possible functions of PARs in oligodendrocytes are still unclear. The present study is the first report about the expression of PARs in oligodendrocytes. OLN-93, a permanent oligodendroglia cell line derived at later stage of differentiation from spontaneously transformed cells in primary rat brain glial cultures, resembles primary cultured oligodendrocytes in its antigenic and morphological properties (RichterLandsberg and Heinrich, 1996) . These cells show characteristics of immature oligodendrocytes and provide a useful model system to study oligodendrocyte functions. The PAR-1-induced calcium signaling pathways were studied here in OLN-93 cells. Moreover, the expression of PAR-1 was found by reverse transcription-polymerase chain reaction (RT-PCR) in primary oligodendrocytes from rat brain.
EXPERIMENTAL PROCEDURES Materials
Human thrombin (1 U/mlϭ15 nM) and human cathepsin G were purchased from Sigma (Deisenhofen, Germany), trypsin from Boehringer (Mannheim, Germany). The synthetic thrombin receptor agonist peptide (TRag, Ala-pFluoro-Phe-Arg-Cha-HomoArgTyr-NH 2 ), rat PAR-2 activating peptide (AP; SLIGRL, Ser-Leu-IleGly-Arg-Leu), mouse PAR-4 AP (GYPGKF, Gly-Tyr-Pro-Gly-LysPhe) and the PAR-1 antagonist peptide (YFLLRNP) were purchased from Neosystem Laboratoire (Strasbourg, France). Human PAR-3 AP (TFRGAP, H-Thr-Phe-Arg-Gly-Ala-Pro-OH) was from Bachem (Heidelberg, Germany). Pertussis toxin (PTX), U73122, U73343 and 2-aminoethoxydiphenylborate (2-APB) were obtained from Calbiochem (La Jolla, CA, USA). Goat polyclonal antibodies against PAR-1 (C-18), PAR-2 (C-17), and were purchased from Santa Cruz (Heidelberg, Germany). mAb-46-1 (mouse monoclonal antibody against myelin protein CNP (2Ј,3Ј-cyclic nucleotide 3Ј-phosphodiesterase)) was prepared by our laboratory (Reiser et al., 1994) . Alexa 488 rabbit anti-mouse IgG antibody, Alexa 555 donkey anti-goat IgG antibody and Fura-2/AM were from Molecular Probes (Eugene, OR, USA). The cell culture medium was from GIBCO/BRL (Eggenstein, Germany) except for fetal calf serum, penicillin and streptomycin which were from Biochrom (Berlin, Germany).
Cell culture
Oligodendroglial cultures were prepared from the flasks after 6 -8 days as previously described (Richter-Landsberg and Vollgraf, 1998) . Briefly, O-2A progenitors, growing on the astrocytic cell layer, were separated by vigorous shaking (for 16 h at 240 r.p.m.) and taken off. Precursor cells were replated on poly-L-lysinecoated culture dishes (3ϫ10 6 cells/10-cm dish) and kept for 7 up to 12 days in serum-free Dulbecco's Modified Eagle medium (DMEM) to which insulin (5 g/ml), transferrin (5 g/ml), and sodium selenite (5 ng/ml; Boehringer) was added. Cells were cultured at 37°C in a CO 2 atmosphere. Growth medium was changed twice a week.
The OLN-93 cell line was derived from rat brain glial cultures (Richter-Landsberg and Heinrich, 1996) . OLN-93 cells were grown in DMEM containing 10% heat-inactivated fetal calf serum, 50 U/ml penicillin and 50 g/ml streptomycin at 37°C and 10% CO 2 .
RNA isolation and RT-PCR
Total RNA was isolated from cultured OLN-93 cells or cultured primary oligodendrocytes with RNeasy mini kit from Qiagen (Hilden, Germany). One microgram of RNA was reversetranscribed using Omniscript RT kit, and the resulting cDNA was amplified by PCR for 35 reaction cycles using HotStarTaq Master Mix kit. The primers used were as follows: PAR-1, forward 5Ј CCTATGAGACAGCCAGAATC 3Ј, reverse 5Ј GCTTCTTGACCT-TCATCC 3Ј; PAR-2, forward 5Ј GCGTGGCTGCTGGGAGGTATC 3Ј, reverse 5Ј GGAACAGAAAGACTCCAATG 3Ј; PAR-3, forward 5Ј GTGTCTCTGCACACTTAGTG 3Ј, reverse 5Ј ATAGCA-CAATACATGTTGCC 3Ј; PAR-4, forward 5Ј GGAATGCCA-GACGCCCAGCATC 3Ј, reverse 5Ј GGTGAGGCGTTGACC-ACGCA 3Ј; glyceraldehyde phosphate dehydrogenase (GAPDH), as a control, forward 5Ј GTGAAGGTCGGTGTCAAC 3Ј, reverse 5Ј CAACCTGGTCCTCAGTGTAGC 3Ј. PCR cycles were performed as follows: denaturation at 95°C for 15 min; then denaturation at 94°C for 60 s, annealing at 51°C (GAPDH), 55°C (PAR-1 and PAR-3), 59°C (PAR-2) or 64°C (PAR-4) for 90 s, and extension at 72°C for 30 s for 35 cycles; finally additional extension at 72°C for 10 min.
Detection of PARs by immunofluorescence
OLN-93 cells were cultured on poly-L-lysine-coated glass coverslips. After washing with PBS, cells were fixed with 4% paraformaldehyde for 20 min at room temperature. For intracellular staining paraformaldehyde-fixed cells were pretreated with 0.2% Triton X-100 in PBS containing 3% BSA for 60 min. Thereafter, cells were incubated with first antibody against PARs (30 g/ml) and CNPase (18 g/ml) for 120 min. After washing, cells were incubated with the second antibody (Alexa 488 rabbit anti-mouse IgG antibody and Alexa 555 donkey anti-goat IgG antibody, 20 g/ml) for 120 min. After further washing, coverslips were fixed and mounted with Aquatex. To check the specificity, the antibodies against PAR-1, PAR-2, PAR-3 and PAR-4 were preincubated with antigen blocking peptides specific for each antibody at room temperature for 2 h in a five-fold (by weight) excess of antigen to antibody. Whole mounts were examined with a LSM510 confocal laser scanning microscope (Carl Zeiss, Jena, Germany).
Cytosolic calcium measurement
The free intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) was determined using the Ca 2ϩ sensitive fluorescent dye Fura-2/AM. For dye loading the cells grown on a coverslip were removed from the culture dish and placed in 1 ml HEPES-buffered saline (HBS) for 30 min at 37°C, supplemented with 2 M Fura-2/AM. The components of HBS are as follows (in mM): NaCl 145, KCl 5.4, MgCl 2 1.8, glucose 25, HEPES 20, pH 7.4 adjusted with Tris (hydroxymethyl) aminomethane. Loaded cells were transferred into a perfusion chamber with a bath volume of about 0.2 ml and mounted on an inverted microscope (Zeiss; Axiovert 135). During the experiments the cells were continuously superfused with medium heated to 37°C.
Single-cell fluorescence measurements of [Ca 2ϩ ] i were performed using an imaging system from TILL Photonics GmbH (Munich, Germany). Cells were excited alternately at 340 nm and 380 nm for 30 -100 ms at each wavelength with a rate of 0.33 Hz and the resultant emission was collected at Ͼ510 nm. Images were stored on a personal computer; the changes in fluorescence ratio (F 340 nm /F 380 nm ) were subsequently determined from selected regions of interest covering single OLN-93 cell.
Statistical analysis
Statistical evaluation was carried out using Student's t-test and Dunnett's multiple comparison test, and PϽ0.05 was considered significant. Data are given as meansϮS.E.M.
RESULTS

RT-PCR detection of PARs in oligodendrocytes
To identify mRNA encoding PARs, mRNA was extracted, reverse transcribed and the resulting cDNA was subjected RNA isolated from primary oligodendrocytes at various times of differentiation (6 h, 1 day, 5 days, 7 days and 12 days) was reverse-transcribed and the resulting cDNA was used as templates to check PAR-1, PAR-2, PAR-3 and PAR-4 expression. Primary oligodendrocytes express PAR-1. The PCR experiments were repeated at least three times with two different preparations giving identical results.
to RT-PCR. We used specific primers to amplify PAR-1, PAR-2, PAR-3 and PAR-4 cDNA from OLN-93 cells. Glyceraldehyde phosphate dehydrogenase (GAPDH, 835 base pairs [bp]) was taken as control for the RT-PCR conditions. The data in Fig. 1 show that OLN-93 cells mainly express PAR-1 (355 bp) and PAR-3 (581 bp), while PAR-2 (742 bp) and PAR-4 (559 bp) are not expressed. The identity of all PCR products was confirmed by sequencing analysis. The sequences of PAR-1 and PAR-3 PCR products are identical to the sequences published in the Genbank (Genbank accession number: NM_012950 for rat PAR-1; AF310076 for rat PAR-3).
Previous analysis of the genes encoding PAR-1, PAR-2, PAR-3 and PAR-4 revealed that all these genes in mouse and human have two exons, which are separated by one intron. The introns of PAR-1 and PAR-2 are about 10 -15 kb long, while the size of the PAR-3 intron is about 4.5 kb. However, the PAR-4 intron is much shorter. The human PAR-4 intron is 274 bp; the mouse PAR-4 intron is only 247 bp. The human PAR-4 intron is inserted at D 37 residue, which is identical to the position E 38 of the mouse intron (Kahn et al., 1998) . Thus, the PAR-4 intron is more easily amplified from genomic DNA compared with the introns of the other PARs. In our experiments (Fig. 1) , the sequence of the PCR product obtained with PAR-4 primers contains 854 bp. Within this sequence, 559 bp are identical to the rat PAR-4 mRNA sequence (Genbank accession number: AF310216). In addition, there is an insert of 295 bp at residue E 37 , which is in the identical position as the human and mouse intron in the respective gene. Thus, this insert sequence corresponds to the hitherto unknown sequence of rat PAR-4 intron which we determined for the first time here (the novel sequence is in Genbank, accession number AY517481). The intron sequence is shown here, as follows from 56 to 350 (exon sequence in bold, italic characters).
51 CCAAG GTGAG TGACTGTGTC TCTTGAAGGG  GTGGATCAGA AATGGAGCTA  101 CTGCTGAGCA GGCTTACAGT CTTGGATCCC  TAAGCCCCCA TGCCTTTGGG  151 GCTGGGCTGT ATCCTTCCAT TCACCAGCCC  AGGGTTCCTG AGTGCTGGAG  201 TGGGGAGGCT TAGGCACCCA CAATACCTAA  GACGCTCAAG GTCATTCTCC  251 CTTCATCTTG TATCCCTAAA GGCAGGGCAG  GGCAGGGCAG GGCAGGGCAG  301 GGCAGGGCAG GGCAGGGAAG GGATT-GACTG ATGTCCCCTC TCTCCCACAG 351 AAGCCTCTCT Thus, the 854 bp band was amplified from genomic DNA template, but not from cDNA. To make this clear, we additionally used mRNA from OLN-93 cells, which was not reverse transcribed, as template to carry out PCR. Again the PCR product of 854 bp was obtained (data not shown). These results indicate that the PAR-4 gene in the OLN-93 cells is silent.
To compare the expression of PARs in the OLN-93 cell line with that of cultured oligodendrocytes derived from rat brain, we checked the expression of PARs mRNA in primary oligodendrocytes at various times of differentiation (6 h, 1 day, 5 days, 7 days and 12 days). The expression of PARs was investigated in cell homogenates of oligodendrocytes. Oligodendrocyte precursor cells were separated from astrocytes, replated and incubated for the indicated times (6 h to 12 days). During the first week in culture precursor cells (6 h), characterized by their bipolar morphology, differentiate into oligodendrocytes with numerous cellular processes, expressing all major myelin specific proteins (Gorath et al., 2001) . We found that oligodendrocytes at all those developmental stages analyzed express PAR-1, while the other three types of PAR could not be detected when we used the same PCR program (35 cycles) which we also used for OLN-93 cells (data in Fig. 2) . However, when the number of PCR cycles in the program was increased to 40, PAR-2 and PAR-3 could also be detected (data not shown). These results suggest that primary cultured oligodendrocytes mainly express PAR-1, and to a lesser extent PAR-2 and PAR-3.
Detection of PARs by immunofluorescence
Indirect immunofluorescence was carried out to study protein expression of PARs in OLN-93 cells, using specific antibodies against PAR-1, PAR-2, PAR-3 and PAR-4 and a monoclonal CNPase antibody (Reiser et al., 1994) . The latter is a marker for oligodendrocytes. Controls were made by omission of the primary antibodies or secondary antibodies. As negative controls PAR antibodies preincubated with specific antigen-blocking peptides were used. 
PAR-mediated Ca 2؉ mobilization in OLN-93 cells
In order to study the functional implications of PARs for oligodendroglial cells, we stimulated OLN-93 cells with 0.5 U/ml thrombin (approximately 7.5 nM), 100 nM trypsin, 5 M thrombin receptor agonist (TRag; PAR-1 agonist; Feng et al., 1995) , 500 M mouse and rat PAR-2 AP (peptide sequence: SLIGRL), 500 M human PAR-3 AP (peptide sequence: TFRGAP) and 500 M mouse PAR-4 AP (peptide sequence: GYPGKF) for 60 s. Thrombin, trypsin and TRag induced a significant [Ca 2ϩ ] i rise ( Fig. 4A-C) . PAR-2 AP and PAR-4 AP, however, had no effect on [Ca 2ϩ ] i mobilization in OLN-93 cells (Fig. 4D, F) . These results suggest that OLN-93 cells do not express detectable PAR-2 and PAR-4, which is consistent with the RT- PCR results. Human PAR-3 AP (TFRGAP), a peptide specific for human PAR-3, not for rat PAR-3, caused only very low amplitude calcium transients (Fig. 4E) . However, until now the possible tethered ligand domain of rat PAR-3 is not yet clear. Other possibilities are that OLN-93 cells do not express functional PAR-3, or alternatively that PAR-3, which has been hypothesized to function as a chaperone for PAR-4 rather than a signaling receptor (NakanishiMatsui et al., 2000) , may play a different role. Fig. 5 represents the concentration-effect curves for thrombin, trypsin and TRag in OLN-93 cells. The points could be fitted by single sigmoidal curves, with EC 50 values of 1.2 nM for thrombin, 17 nM for trypsin and 1.6 M for TRag.
Desensitization of PAR-1 and ligand cross-reactivity in OLN-93 cells
In order to study the desensitization of PARs in OLN-93 cells, we stimulated cells for a second time with proteases (test pulse of 60 s), at 5 min interval after the first stimulus (pre-pulse of 60 s). Fig. 6 A-F demonstrates six alternative ways to stimulate cells consecutively with thrombin, trypsin and TRag. We analyze the mutual influence of stimulation by proteolysis or by peptide application.
The results of the experiments exemplified in Fig. 6 are summarized in Fig. 7 . They indicate that a first proteolytic stimulation with either thrombin or non-proteolytic stimulation with TRag reduced the amplitude caused by thrombin as second agonist only by 41% and 49%, respectively. However, a second addition of thrombin after a pre-pulse challenge with trypsin reduced the calcium transient to a much larger degree (by 80%). When the second pulse (test pulse) contained trypsin, after firstly stimulating nonproteolytically with TRag, the calcium response was reduced weakly (by 28%), while the application of trypsin by the test pulse after first proteolytic stimulation with thrombin or trypsin caused a largely reduced intracellular calcium response (by 73% and 80%, respectively).
Cathepsin G is a neutrophil-derived protease that has been shown to inhibit the effects of thrombin on some cells expressing thrombin receptors, while acting as an agonist on some other cells, and hence has cell type specific effects (Molino et al., 1995) . To further clarify desensitization and cross-reactivity of PAR-1 in OLN-93 cells, we used cathepsin G (0.01 U/ml) as first agonist (pre-prepulse) to stimulate cells, and then after a second agonist (pre-pulse) of trypsin (100 nM), thrombin (0.5 U/ml) was employed as third agonist (test pulse; Fig. 8A ). In addition, we also studied desensitization of PARs in other ways. The summary of the results is presented in Fig. 8B . Our experiments show that cathepsin G caused only very limited or negligible intracellular calcium mobilization, but it significantly reduced the amplitude induced by secondly adding thrombin, trypsin or TRag, by 41%, 20% and 33%, respectively (Fig. 8B ). This indicates that cathepsin G cannot activate PARs in OLN-93 cells by itself, but it cleaves PARs at some site which affects the responsiveness that can be elicited by the agonists thrombin, trypsin and TRag.
To evaluate the differences in desensitization caused by either three or two successive pulses of different agonists, the most important results are presented as a numerical comparative overview in Table 1 . Data in Table 1 show that cathepsin G reduced the calcium responses induced by test pulses of thrombin, trypsin and TRag after respective pre-pulses to a different degree. The pre-pulse of trypsin reduced the calcium response induced by a test pulse of thrombin by 80%. The reduction was similar after pre-pre-pulse of cathepsin G and pre-pulse of trypsin (76%). Thrombin as pre-pulse abolished the trypsininduced calcium response by 73%, which is similar to the effects of cathepsin G and thrombin as two consecutive pre-pulses abolishing the trypsin-induced calcium responses (by 68%). In addition, the non-proteolytic stimulation with TRag reduced thrombin-induced calcium responses only by 49%. Similarly, consecutive challenges with cathepsin G and TRag also suppressed the thrombininduced calcium response only by 44%.
However, the amplitude induced by trypsin as third stimulus (test pulse) after consecutive cathepsin G and TRag stimuli was reduced by 62%. This was significantly more than the degree of desensitization of the response to trypsin by a preceding application of TRag (by 28%). Thus, cathepsin G has no effect on the calcium responses induced by the addition of thrombin as a third pulse, given after a pre-pulse of TRag or trypsin. However, cathepsin G had a remarkable reducing effect on a test pulse of trypsin after TRag stimulation. This potentiation was not seen after thrombin pre-pulse stimulation.
Elucidation of the signaling mechanism of PAR-1-induced Ca 2؉ rise
To study the calcium source for the transient intracellular calcium rise, we compared the amplitude induced by thrombin, trypsin and TRag in the presence of extracellular Ca 2ϩ (1.8 mM CaCl 2 ) and in its absence (no CaCl 2 added). Omission of extracellular Ca 2ϩ reduced the amplitude induced by thrombin, trypsin and TRag by 31%, 25% and 15%, respectively (Fig. 9) . These results indicate that elevation of intracellular calcium induced by PARs mainly results from Ca 2ϩ release from intracellular stores, and only to a small extent (15%-30%) from Ca 2ϩ influx. One major aim of this study is to investigate whether the intracellular calcium response in OLN-93 cells is generated through PAR-1 activation or through both PAR-1 and PAR-3 activation. In this experiment, we preincubated cells with the thrombin receptor (PAR-1) antagonist (YFLL-RNP, 200 M) during the 30 min Fura-2/AM loading period, and then studied the [Ca 2ϩ ] i responses induced by thrombin, trypsin and TRag. Fig. 10 shows that YFLLRNP reduced the [Ca 2ϩ ] i responses induced by thrombin, trypsin and TRag by 94%, 88% and 96%, respectively. These results suggest that the [Ca 2ϩ ] i responses induced by thrombin, trypsin and TRag are almost exclusively due to activation of PAR-1, but not of PAR-3. Whether rat PAR-3 can be activated by thrombin needs further investigations.
It is well known that PTX can inactivate the G i /G o family but does not affect G s , G q and G 12/13 . To study whether in oligodendrocytes the signaling cascade from PAR-1 is mediated through the G i /G o family or other G proteins, cells were preincubated with PTX (200 ng/ml) for 24 h before the stimulation. As shown in Fig. 10 , the increase of intracellular calcium evoked by thrombin and trypsin was attenuated by only 33% and 16%, respectively. But PTX [Ca 2ϩ ] i responses to 0.5 U/ml thrombin (test pulse), obtained at 5 min after a first addition (pre-pulse) of 0.5 U/ml thrombin, 100 nM trypsin or 5 M TRag, respectively. The traces in C, D and F show [Ca 2ϩ ] i responses to 100 nM trypsin (test pulse), obtained at 5 min after the first application (pre-pulse) of 100 nM trypsin, 0.5 U/ml thrombin or 5 M TRag, respectively. The traces are the mean responses from at least 10 single cells measured in a single experiment. The delay in the onset of the response is caused by the perfusion system. had virtually no effect on the [Ca 2ϩ ] i response induced by TRag. These results indicate that the calcium signaling cascade from PAR-1 was mediated mainly through PTXinsensitive G proteins.
Previous data already showed that PARs activate phospholipase C (PLC), which converts membrane bound phosphatidyl inositol (4,5)-bisphosphate into inositol trisphosphate (InsP 3 ) and diacylglycerol. InsP 3 diffuses into the cytoplasm and triggers release of Ca 2ϩ from the endoplasmic reticulum by binding to InsP 3 receptors (Wang et al., 2002b) . To determine whether PLC and InsP 3 are upstream factors of the Ca 2ϩ release from the stores, cells were superfused with 5 M U73122 (PLC antagonist), U73343 (an inactive analog of U73122), and 500 M 2-APB (InsP 3 receptor antagonist) for 5 min before the stimulation. The thrombin-induced [Ca 2ϩ ] i responses and trypsin-induced [Ca 2ϩ ] i responses were both blocked by U73122 by 60% and 46%, respectively. Surprisingly, TRag-induced [Ca 2ϩ ] i response was blocked very weakly (only by 14%), as shown in Fig. 10 . The inactive analog U73343 had no effect on [Ca 2ϩ ] i mobilization in OLN-93 cells. These results implicate that thrombin, trypsin and TRag induced the [Ca 2ϩ ] i responses at least in part via the PLC activation. 2-APB, a non-competitive antagonist of the intracellular InsP 3 receptor, almost completely inhibited the [Ca 2ϩ ] i responses induced by thrombin, trypsin and TRag. These results are consistent with the data determining the source of calcium (Fig. 9) .
DISCUSSION
PARs have already been demonstrated on neurons, astrocytes and microglia cells. In peripheral and central neurons, PARs possibly are involved not only in neurogenic inflammation and neurodegenerative processes, but also in nociception (Vergnolle et al., 2001) . Also, PAR-1 determines the effects of thrombin on cell morphology, calcium mobilization, and caspase-mediated apoptosis (Smirnova et al., 2001) . In microglia cells, PAR-1 directly contributes to thrombin-induced microglial proliferation and participates in thrombinmediated microglia activation, where it induces a rapid increase in [Ca 2ϩ ] i (Moller et al., 2000; Suo et al., 2002) . In astrocytes, PARs can modulate cell proliferation via activation of the extracellular signal-regulated kinase (ERK) pathway (Wang et al., 2002b; Wang and Reiser, 2003) .
In contrast to astrocytes, which functionally express all four types of PARs (Wang et al., 2002a) , OLN-93 oligodendroglial cells functionally express PAR-1, whereas PAR-3 seems to be expressed without apparent functional activity. These results were further supported by indirect immunofluorescence data, which demonstrate the distinct presence of PAR-1 and PAR-3 protein on the cell surface of OLN-93 cells in colocalization with CNPase. CNPase is an oligodendroglial marker which in the CNS is predominantly found in the CNS myelin in the oligodendroglia membrane, in paranodal segments and in periaxonal regions (Muraro et al., 2002) . Furthermore, primary oligodendrocytes only express PAR-1.
In the present study, results from cytosolic Ca 2ϩ measurements proved that thrombin, trypsin and TRag mobilized intracellular free Ca 2ϩ , but APs of PAR-2 and PAR-4 could not cause intracellular free Ca 2ϩ mobilization. Human PAR-3 AP (TFRGAP) induced a very small calcium response, with an amplitude (⌬ F 340 nm /F 380 nm ) of only about 0.02. In contrast, our previous data had shown that TFRGAP was considerably more effective in inducing Ca 2ϩ signaling in astrocytes (Wang et al., 2002a) .
Results from the desensitization assay (Fig. 7) and experiments with the PAR-1 antagonist peptide YFLLRNP ( Fig. 10) prove that thrombin activates PAR-1, but not PAR-3 in OLN-93 cells. Trypsin, the agonist of PAR-2, can similarly activate PAR-1. It still remains unknown whether thrombin can activate rat PAR-3 or not. Rat PAR-3 has a glutamyl residue at position P1 of the cleavage site (Owen, 2003) , which makes hydrolysis by thrombin very unlikely at all. This suggests that rat PAR-3 cannot be activated by thrombin. In addition, the concept was put forward that PAR-3 is a non-signaling cofactor, aiding the activation of PAR-4 by thrombin in mouse platelets (Nakanishi-Matsui et al., 2000) . A major aim of the present study was to investigate desensitization of PARs in OLN-93 cells by thrombin, trypsin and cathepsin G. It is established that trypsin cleaves peptides C-terminally to Arg or Lys residues, and that it prefers Gly or Pro residues in P2 position (Zhao et al., 2003) . Sequence analysis of rat PAR-1 revealed two potential cleavage sites for trypsin: Pro 44 -Arg 45 and Gly 76 -Arg 77 . The data in Fig. 7 , Fig. 8 and Table 1 show that the proteases thrombin and trypsin both induce a similar degree of calcium mobilization in OLN-93 cells. However, from the thrombin-induced Ca 2ϩ responses, it seems that a pre-pulse of trypsin induces a larger desensitization than a pre-pulse of thrombin does. This difference was similarly seen in our previous results obtained with rat astrocytes (Ubl et al., 1998) . Surprisingly, trypsin stimulation after the pre-pulse addition of thrombin shows a comparably large desensitization as trypsin stimulation after the pre-pulse challenge with trypsin. The reason might be that trypsin can cleave rat PAR-1 at the two positions indicated above. The example trace in A shows the Ca 2ϩ response indicated by the fluorescence ratio (F 340 nm /F 380 nm ), the bars in chart B represent the maximum changes in the fluorescence ratio (⌬ F 340 nm /F 380 nm ) seen with the test pulse. (A) OLN-93 cells were first exposed to 0.01 U/ml cathepsin G (cat G; pre-pre-pulse), followed by second addition of 100 nM trypsin (pre-pulse), then cells were stimulated by third agonist 0.5 U/ml thrombin (test pulse). (B) OLN-93 cells were first exposed to 0.01 U/ml cathepsin G (Cat G; pre-pre-pulse), followed by second addition (pre-pulse) of 100 nM trypsin or 5 M TRag, then cells were stimulated by third agonist (test pulse) 0.5 U/ml thrombin, or cells were exposed to 0.5 U/ml thrombin or 5 M TRag (pre-pulse) 3-5 min after first addition of 0.01 U/ml cathepsin G (pre-pre-pulse), 3-5 min thereafter 100 nM trypsin (test pulse) were added. The data shown are the meanϮS.E.M. of n single cells (numbers of cells given above the respective column) measured from at least three different experiments and two different cell preparations. The statistical significance level for difference from control is given as: * Cathepsin G has been shown to have two apparently contradictory effects. In some cells that express thrombin receptors, including platelets (LaRosa et al., 1994; Molino et al., 1992) and porcine aortic endothelial cells (Totani et al., 1994) , cathepsin G acts as an agonist causing [Ca 2ϩ ] i mobilization. In contrast, in human umbilical vein endothelial cells (Weksler et al., 1989) and fibroblasts (Selak, 1994) (Molino et al., 1995) . Previously it has already been shown that cathepsin G might cleave C-terminally to Lys, Phe, Arg and Leu, and that cathepsin G prefers a Pro residue in P2 position (Polanowska et al., 1998 (Sambrano et al., 2000) .
Our results show that cathepsin G has no effect of its own on Ca 2ϩ release. Moreover, cathepsin G reduced the calcium responses induced by a second stimulation (test pulse) with thrombin, trypsin or TRag to a different degree (Fig. 8) . Thus, we conclude that cathepsin G probably partially cleaved PAR-1 of OLN-93 cells at sites, which might result in inhibition of the effects of thrombin, trypsin and Trag. However, cathepsin G did not affect the reduction of the calcium responses induced by the addition of thrombin and trypsin as third agonist (test pulse), given after a pre-pulse of the other proteases ( Fig. 8 and Table  1 ). The only striking effect was seen when trypsin was given as the test pulse after cathepsin G (pre-pre-pulse) and TRag (pre-pulse) challenges. The desensitization of 62% achieved in that case was much more than that induced by a TRag pre-pulse before a trypsin test-pulse (28%). This potentiation seems to be due to a still not yet clearly identified cleavage site of cathepsin G in rat PAR-1.
It has been well established in our previous analysis that in astrocytes the signaling cascade from PAR-1 to the ERK pathway is mediated through PTX-sensitive as well as PTX-insensitive G proteins (Wang et al., 2002b) . In the present study, we found that in OLN-93 oligodendrocytes The responses induced by thrombin (0.5 U/ml) or trypsin (100 nM) only were regarded as control. For desensitization experiments OLN-93 cells were stimulated successively by two or three different agonists. As shown in Fig. 6 , OLN-93 cells were exposed to two successive pulses (pre-pulse and test pulse), or as shown in Fig. 8B , cells were treated by three successive stimuli. Cells were firstly exposed to human cathepsin G (0.01 U/ml; pre-pre-pulse), with a following stimulation of thrombin (0.5 U/ml), trypsin (100 nM) or TRag (5 M; pre-pulse), then cells were stimulated with the third agonist (thrombin or trypsin) as test pulse. Each stimulation lasted for 1 min. the calcium signaling cascade from PAR-1 was mediated mainly through PTX-insensitive G proteins.
Our previous data showed that prolonged (30 min) incubation with 10 M U73122 but not with 10 M of the inactive analog U73343 completely abolished the trypsinevoked Ca 2ϩ response in the epithelial cell lines (Ubl et al., 2002) . In the present study, 10 M U73122 treatement of OLN-93 cells reduced Ca 2ϩ responses induced by thrombin, trypsin and TRag by 60 -70% (data not shown). However, such high concentration of U73122 will affect basal Ca 2ϩ mobilization by itself. To avoid this problem, the lower concentration (5 M) of U73122 was used in our study. Fig. 10 shows that the PLC antagonist U73122 significantly reduced the calcium responses induced by thrombin, trypsin and TRag. However, the reduction by U73122 was very limited. In addition, the calcium response caused by TRag was much less reduced than those of thrombin and trypsin. The narrow inhibitory range of U73122 might be due to the fact that U73122 is not a selective inhibitor of PLC (see for example Walker et al., 1998) . Otherwise PLC activation might depend on the mode of PAR activation. 2-APB almost completely abolished the calcium responses induced by thrombin, trypsin and TRag. These results suggest that liberation of InsP 3 was the event upstream of the Ca 2ϩ release from the stores.
To summarize, the present data demonstrate that shortterm stimulation of OLN-93 oligodendroglial cells with thrombin, trypsin and PAR-1 AP (TRag) dose-dependently induced a transient rise of [Ca 2ϩ ] i , which mainly resulted from Ca 2ϩ release from intracellular stores. Desensitization experiments indicated the influence of cathepsin G on PAR-1 activation, and also elucidated the mechanism of rat PAR-1 desensitization. Experiments investigating the effects of PTX, U73122 and 2-APB, showed that in OLN-93 cells the calcium signaling cascade from PAR-1 was mediated through PTX-insensitive G proteins, the activation of PLC and the liberation of InsP 3 . This is the first study to show that OLN-93 oligodendrocytes functionally express PAR-1, and that PAR-1 is coupled to the mobilization of intracellular calcium. It will be an interesting task for the future to clarify the functions of oligodendroglial PAR-1 in vivo. 
